| Date Filed | Type | Description |
| 03/02/2023 |
4
| Gergen Mark J (President and CEO) has filed a Form 4 on Poseida Therapeutics, Inc.|
Txns:
| Granted 269,586 shares
@ $0
Granted 364,060 options to buy
@ $5.35, valued at
$1.9M
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2022 |
4
| Gergen Mark J (President and CEO) has filed a Form 4 on Poseida Therapeutics, Inc.|
Txns:
| Granted 357,200 shares
@ $0
Granted 518,500 options to buy
@ $4.75, valued at
$2.5M
|
|
| 02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2020 |
4
| Gergen Mark J (President and CBO) has filed a Form 4 on Poseida Therapeutics, Inc.|
Txns:
| Granted 75,000 options to buy
@ $16, valued at
$1.2M
|
|
| 07/09/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/02/2016 |
4
| Gergen Mark J (SVP, COO) has filed a Form 4 on HALOZYME THERAPEUTICS INC|
Txns:
| Granted 333,890 options to buy
@ $9.97, valued at
$3.3M
|
|
| 09/02/2016 |
3
| Gergen Mark J (SVP, COO) has filed a Form 3 on HALOZYME THERAPEUTICS INC |
| 01/26/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/19/2016 |
4
| Gergen Mark J (Executive VP, COO) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Sold 10,000 shares
@ $25.9211, valued at
$259.2k
Exercised 5,000 options to buy
@ $8.5, valued at
$42.5k
Exercised 10,000 options to buy
@ $8.5, valued at
$85k
|
|
| 02/05/2015 |
4
| Gergen Mark J (Exec. VP and COO) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $21.51, valued at
$645.3k
|
|
| 05/23/2014 |
4
| Gergen Mark J (Exec. VP and COO) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $17.41, valued at
$870.5k
|
|
| 07/18/2013 |
4
| Gergen Mark J (Exec. VP and COO) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 132,000 options to buy
@ $8.5, valued at
$1.1M
|
|
| 08/10/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/26/2012 |
4
| Gergen Mark J (SVP, Corporate Development) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC|
Txns:
| Granted 936 shares
@ $14.62, valued at
$13.7k
|
|
| 03/07/2012 |
4
| Gergen Mark J (SVP, Corporate Development) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 1,529 shares
@ $0
Granted 8,379 options to buy
@ $16.02, valued at
$134.2k
Granted 91,621 options to buy
@ $16.02, valued at
$1.5M
|
|
| 03/02/2012 |
4
| Gergen Mark J (SVP, Corporate Development) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC|
Txns:
| Sold 1,846 shares
@ $17.11, valued at
$31.6k
|
|
| 02/24/2012 |
4
| Gergen Mark J (SVP, Corporate Development) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC|
Txns:
| Granted 20,000 shares
@ $0
Sold 7,518 shares
@ $17.0302, valued at
$128k
|
|
| 01/12/2012 |
4
| Gergen Mark J (SVP, Corporate Development) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC|
Txns:
| Granted 15,000 shares
@ $0 |
|
| 02/04/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/06/2009 |
4
| Gergen Mark J (Sr VP Corporate Development) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC |
| 02/05/2009 |
4
| Gergen Mark J (Sr VP Corporate Development) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC |